Probiotic-Associated Central Venous Catheter Bloodstream Infections Lead to Increased Mortality in the ICU*
Authors:
- 1 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 51 (11) , 1469-1478
Abstract
OBJECTIVES: To determine the occurrence rate and impact on patient outcomes of probiotic-associated central venous catheter bloodstream infections in the ICU. DESIGN: Retrospective observational cohort study. SETTING: The cohort was gathered using HCA Healthcare’s data warehouse. PATIENTS: Adult patients with central venous catheters in the ICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Blood culture data were used to determine whether an infection had occurred with an organism contained in an administered probiotic. Eighty-six probiotic-associated central venous catheter bloodstream infections were identified among the 23,015 patient cohort who received probiotics (0.37%). The number needed to harm was 270. Zero infections were found in the cohort that did not receive probiotics. Patients who contracted a probiotic infection had increased mortality (odds ratio, 2.23; 1.30–3.71; p < 0.01). Powder formulations had an increased rate of infection compared with nonpowder formulations (0.76% vs 0.33%; odds ratio, 2.03; 1.05–3.95; p = 0.04). CONCLUSIONS: Probiotic administration is associated with a substantial rate of probiotic-associated bloodstream infection in ICU patients with central venous catheters in place. Probiotic-associated bloodstream infections result in significantly increased mortality. Powder formulations cause bloodstream infections more frequently than nonpowder formulations. In ICU patients with central venous catheters, the risks of probiotic-associated central venous catheter bloodstream infection and death outweigh any potential benefits of probiotic administration.Keywords
This publication has 33 references indexed in Scilit:
- The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trialThe American Journal of Clinical Nutrition, 2013
- Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trialsThe American Journal of Clinical Nutrition, 2010
- Clostridium difficile Infection in the Intensive Care UnitInfectious Disease Clinics of North America, 2009
- Options thérapeutiques médicamenteuses et diététiques actuellesGastroentérologie Clinique Et Biologique, 2009
- Probiotics for Prevention of Antibiotic-associated DiarrheaJournal of Clinical Gastroenterology, 2008
- Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofunginCritical Care, 2008
- Invasive Saccharomyces Infection: A Comprehensive ReviewClinical Infectious Diseases, 2005
- Saccharomyces cerevisiae Fungemia: An Emerging Infectious DiseaseClinical Infectious Diseases, 2005
- Supply of Pre- and Probiotics Reduces Bacterial Infection Rates After Liver Transplantation—A Randomized, Double-Blind TrialAmerican Journal of Transplantation, 2005
- Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipientsTransplantation, 2002